T cells targeting multiple tumor-associated antigens in lymphoma
Catherine Bollard • 4 Dec 2015
Panel discussion on T-cell lymphoma: current status of therapy and progress
Elaine Jaffe et al. • 23 Sep 2016
Phase II trial of venetoclax monotherapy for relapsed/refractory CLL with 17p deletion
John Gribben et al. • 3 Dec 2015
12th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2014: Day 2 meeting highlights
Anton Hagenbeek et al.
Will knowledge of the molecular pathology of lymphoma improve clinical trials?
David Maloney et al.
Updates from a Phase I clinical trial examining ublituximab in combination with TGR-1202
Owen O'Connor • 9 Jun 2016
iwNHL 2015 roundtable: Molecular biology of T-cell lymphoma
Francesco d'Amore et al. • 3 Oct 2015
ZUMA-7 subgroup analysis: axi-cel vs SOC in elderly patients with R/R LBCL
Anna Sureda • 12 Jun 2022